Clinical overview and outcome in a cohort of children with polyarteritis nodosa

Clin Exp Rheumatol. 2014 May-Jun;32(3 Suppl 82):S134-7. Epub 2014 Feb 11.

Abstract

Objectives: Polyarteritis nodosa (PAN) is a rare vasculitis in childhood and poor information is known about its long-term outcome. Our aim was to describe the clinical features, at onset and during the disease course, of childhood-onset PAN and identify a potential correlation with persistent organ damage and worse outcome in a cohort of paediatric patients with a confirmed diagnosis of PAN.

Methods: A retrospective collection of demographic and clinical data of 52 Caucasian children diagnosed with PAN, fulfilling the EULAR/PRES diagnostic criteria, recruited from eight paediatric rheumatologic centres and one transition unit, was performed. A statistical correlation was made between clinical involvement at onset or during the overall disease course and patients' final outcome.

Results: Data from 52 patients (31 males, 21 females) were collected: their mean age at onset was 7.9 years (median 6.3) and mean follow-up period was 6.2 years (median 5.4). At the last follow-up visit, 27 patients (51.9%) were off therapy in clinical remission, 17 (32.7%) were in clinical remission while on medication, and 6 (11.6%) had a persistent or relapsing disease course. Two patients (3.8%) deceased because of severe cerebral involvement. Cranial nerve palsy during the disease course was significantly correlated with a worse prognosis (p=0.011). The presence of nephrogenic hypertension at onset and seizures during the disease course were significantly associated with the development of irreversible organ damage (p= 0.040 and 0.011, respectively).

Conclusions: Childhood PAN is a severe disease with substantial risk of long-term morbidities. In our cohort of patients the worst outcome was significantly correlated with renal and neurological involvement.

MeSH terms

  • Adolescent
  • Age of Onset
  • Child
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Italy / epidemiology
  • Male
  • Organ Dysfunction Scores
  • Patient Acuity
  • Polyarteritis Nodosa* / complications
  • Polyarteritis Nodosa* / diagnosis
  • Polyarteritis Nodosa* / drug therapy
  • Polyarteritis Nodosa* / epidemiology
  • Polyarteritis Nodosa* / physiopathology
  • Prognosis
  • Remission Induction
  • Retrospective Studies
  • Risk Assessment
  • Secondary Prevention
  • Time
  • Vasculitis, Central Nervous System / epidemiology
  • Vasculitis, Central Nervous System / etiology*
  • Vasculitis, Central Nervous System / physiopathology

Substances

  • Immunosuppressive Agents